George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

18 Feb 2021 15:07

RNS Number : 6286P
Craven House Capital PLC
18 February 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Craven House Capital PLC

 

("Craven House" or the "Company")

 

Unaudited Interim Report for the period ended 30 November 2020

 

 

 

 

 

 

 

INVESTMENT MANAGER'S REPORT FOR THE SIX MONTH PERIOD ENDED

30 NOVEMBER 2020

 

 

Statement by the Investment Manager

 

Following the restructuring approved by shareholders on 22 May 2020, the Company's investment portfolio is significantly simplified and comprises minority shareholdings in five Swedish-managed eCommerce businesses.The Company's investments are held at fair value in accordance with the IPEVC guidelines. Given the proximity of the acquisition date of the shareholdings in the businesses listed below to the period end, the original acquisition price of "Price of Recent Investment" has been applied as the valuation methodology.

 

Investment

Value at 30 Nov 2020

Value at 31 May 2020

Shares in Garimon Ltd

$1,600,000

$1,600,000

Shares in Rosedog Ltd

$1,600,000

$1,600,000

Shares in OneBas.com Ltd

$1,600,000

$1,600,000

Shares in IZYRadio Ltd

$1,600,000

$1,600,000

Shares in YRRO Ltd

$1,600,000

$1,600,000

 

 

 

 

 

We are confident that the impact of the COVID-19 pandemic has not impaired the prospects or therefore the valuation of these businesses since the time of acquisition. Their respective strategies, which include the online marketing and distribution of magazines, music and dietary supplements are, in fact, likely to benefit from the shift in consumer behaviour resulting from the pandemic. The development of each business remains at an early stage and we look forward to reporting on material developments within the portfolio as appropriate.

 

Transactions after the period end

 

On 9 December 2020, the Company announced that Black Seas Property AS ("BSP") entered into a 6 month option agreement to acquire certain brand names and associated rights from its investee company YRRO Ltd. Under the terms of the agreement, consideration payable of NOK 130,000,000 is to be settled by the issuance of new shares in BSP to the shareholders of YRRO Ltd.

 

 

Desmond Holdings LtdInvestment Manager to Craven House Capital Plc

 

 

 For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/James Keeshan

www.Sparkadvisorypartners.com

 

 

Tel: 0203 368 3550

 

 

 About Craven House Capital:

The Company's Investing Policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-Commerce sector.

 

 

 

 

 

 

 

 

 

 

 

 

 

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

 

Six months ended

Year Ended

30 Nov 2020

30 Nov 2019

31 May 2020

(Unaudited)

)

(Unaudited)

(Audited)

$'000

$'000

$'000

CONTINUING OPERATIONS

Changes in fair value

-

(6,893)

(6,892)

 

Intercompany loans written off

 

Investment Manager fee waived

 

-

 

-

 

-

 

1,657

 

(7,158)

 

1,446

 

Other income

 

2

 

-

 

 

-

 

144

 

Administrative expenses

(119)

(440)

(727)

OPERATING LOSS

(119)

(5,676)

(13,187)

 

LOSS BEFORE INCOME TAX

 

(119)

 

(5,676)

 

(13,187)

Income tax

3

-

-

-

LOSS FOR THE PERIOD

(119)

(5,676)

(13,187)

Earnings per share expressed

In cents per share:

Basic and diluted

6

(3.08)

(223.70)

(456.52)

 

 

 

 

 

 

 

 

 

 

3

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF FINANCIAL POSITION

AS AT 30 NOVEMBER 2020

 

 

Six months ended

Year Ended

 

30 Nov 2020

30 Nov 2019

31 May 2020

 

(Unaudited)

(Unaudited)

(Audited)

 

$'000

$'000

$'000

 

ASSETS

NON-CURRENT ASSETS

Investments at fair value through

profit or loss

4

8,000

20,476

8,000

8,000

20,476

8,000

CURRENT ASSETS

Trade and other receivables

28

951

46

Cash and cash equivalents

3

16

6

31

967

52

TOTAL ASSETS

8,031

21,443

8,052

EQUITY

SHAREHOLDERS' EQUITY

Called up share capital

5

3,802

12,759

3,802

Share premium

11,153

25,443

11,153

Accumulated deficit

(7,276)

(20,342)

(7,157)

TOTAL EQUITY

7,679

17,860

7,798

LIABILITIES

CURRENT LIABILITIES

Trade and other payables

352

3,083

254

NON-CURRENT LIABILITIES

Loans and borrowings

7

-

500

-

TOTAL LIABILITIES

352

3,583

254

TOTAL EQUITY AND LIABILITIES

8,031

21,443

8,052

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

 

 

 

Called up share capital

$'000

 

Share premium

$'000

 

Accumulated deficit

$'000

 

 

 

Total

$'000

 

Balance at 1 June

2019

 

 

12,594

 

 

25,128

 

 

(14,666)

 

 

23,056

Changes in equity

Issue of share capital

165

315

-

480

Transactions with owners

12,759

25,443

(14,666)

23,536

Loss for the period

-

-

(5,676)

(5,676)

Balance at 30 November 2019

 

12,759

 

25,443

 

(20,342)

 

17,860

Changes in equity

Issue of share capital

Cancellation of deferred shares

Reduction in share premium

Dividend in specie

1,200

 

(10,157)

-

-

10,710

 

-

(25,000)

-

-

 

10,157

25,000

(14,461)

11,910

 

-

-

(14,461)

Transactions with owners

3,802

11,153

354

15.309

Loss for the period

-

-

(7,511)

(7,511)

Balance at 31 May

2020

 

3,802

 

11,153

 

(7,157)

 

7,798

Changes in equity

Issue of share capital

-

-

-

-

Transactions with owners

3,802

11,153

(7,157)

7,798

Loss for the period

-

-

(119)

(119)

Balance at 30 November

2020

 

3,802

 

 

 

11,153

 

(7,276)

 

(7,679)

CRAVEN HOUSE CAPITAL PLC

 

STATEMENT OF CASH FLOWS

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

Six months ended

Year Ended

30 Nov 2020

30 Nov 2019

31 May 2020

(Unaudited)

(Unaudited)

(Audited)

$'000

$'000

$'000

Cash flows from operating activities

Loss before income tax

Adjustments for non-cash items

Fair value movement arising on investments

Intercompany loans written off

Management fee accrual waived

Costs paid by shares

Repairs

Dividend income

Decrease/(increase) in trade and other receivables

Increase/(decrease) in trade and other payables

Decrease in loans and borrowings

Non-cash issue of ordinary shares

 

(119)

 

-

-

-

-

-

-

 

18

98

-

-

 

(5,676)

 

6,893

-

-

-

-

-

 

(18)

(1,409)

(300)

480

 

(13,187)

 

6,892

7,158

(1,657)

190

5

(144)

 

(3,394)

103

-

-

Net cash used in operating activities

 

Cash flows from investing activities

(3)

 

(30)

(4,034)

Dividends received from joint ventures and associates

 

-

 

-

 

144

Net cash generated by investing activities

-

-

144

Cash flows from financing activities

Proceeds from issue of shares

Repayment of loan

-

-

-

-

3,900

(50)

Net cash from financing activities

-

-

3,850

 

Net decrease in cash and cash equivalents

 

(3)

 

(30)

 

(40)

Cash and cash equivalents at the beginning

of the period

6

46

46

Cash and cash equivalents at the end of the period

 

3

 

16

 

6

 

 

 

 

6

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

 

1. ACCOUNTING POLICIES

 

General Information

Craven House Capital Plc is a company incorporated in the United Kingdom under the Companies Act 2006. The address of the registered office is given on the company information page. The Company is listed on the AIM Market of the London Stock Exchange (ticker: CRV).

 

The next annual financial statements of Craven House Capital Plc will be prepared in accordance with applicable International Financial Reporting Standards (IFRS) as adopted for use by the European Union. Accordingly, the interim financial information in this report has been prepared using accounting policies consistent with IFRS. IFRS are subject to amendment and interpretation by the International Accounting Standards Board (IASB) and the International Financial Reporting Interpretations Committee (IFRIC) and there is an on-going process of review and endorsement by the European Commission. The financial information has been prepared on the basis of the IFRS that the directors expect to be applicable as at 31 May 2020.

 

The financial information has been prepared under the historical cost convention, except to the extent varied for fair value adjustments required by accounting standards, and in accordance with applicable International Financial Reporting Standards (IFRS) as adopted for use by the European Union. The principal accounting policies have been applied to all periods presented.

 

This financial information is unaudited and does not constitute statutory financial statements within the meaning of Section 434 of the Companies Act 2006. The financial statements of the Company for the year ended 31 May 2020, which were prepared in accordance with IFRS as adopted for use by the European Union, have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors was unqualified and did not include any statement under Section 498 of the Companies Act 2006.

 

This financial information is presented in United States dollar, rounded to the nearest $'000.

 

The directors do not propose the issuance of a dividend.

 

The interim financial information for the six months ended 30 November 2020 was approved by the directors on 18th February 2021.

 

Going concern

The directors consider that the Company is well placed to manage its business risks successfully and have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the financial information.

 

 

 

 

 

7

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

 

 

2. Other operating income

 

Six months ended

Year Ended

30 Nov 2020

30 Nov 2019

31 May 2020

(Unaudited)

(Unaudited)

(Audited)

$'000

$'000

$'000

 

Dividends received

-

-

144

 

-

-

144

 

 

 

3. Taxation

 

No tax charges arose in the period or in comparative periods as a result of losses incurred.

 

 

4. Investments at fair value through profit or loss

 

 

 

 

 

Unquoted equity investments

$'000

 

 

 

Total

$'000

As at 1 June 2020 and 30 November 2020

8,000

8,000

As part of a group reconstruction in May 2020, the Company's beneficial ownership of its historic portfolio was transferred to Ordinary Shareholders via a dividend in specie of shares in its wholly owned subsidiary, Craven Industrial Holdings Plc.

 

The value of Investments therefore represents the Company's acquisitions on 13 March 2020 of a 29.9% interest, at consideration of $1.6m each, in the below-named five UK entities. These are all unquoted investments and have therefore been measured on a Level 3 basis as no observable market data is available. Further information on each investment holding is as follows;

 

Shares in Garimon Ltd are valued at $1,600,000 representing a 29.9% holding. This shareholding has been valued on a Price of Recent Investment basis which the directors consider represents the best indication of the fair value at the year end. Garimon is the owner of "Magazinos.com", the world's largest-by-content on-line media magazine and periodical content provision service. The management of Magazinos are currently evaluating options available to broaden Magazinos' shareholder base by means of IPO and/or partnering with a major industry investor.

 

Shares in Onebas.com Ltd are valued at $1,600,000 representing a 29.9% holding. This shareholding has been valued on a Price of Recent Investment basis which the directors consider represents the best indication of the fair value at the year end. Onebas.com Ltd is the owner of "ONEBas.com Music", an optimised search engine providing a portal to music content freely circulating online.

 

8

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

 

 

4. Investments at fair value through profit or loss (continued)

 

Shares in IZYRadio Ltd are valued at $1,600,000 representing a 29.9% holding. This shareholding has been valued on a Price of Recent Investment basis which the directors consider represents the best indication of the fair value at the year end. IZYRadio Ltd is a UK/Swedish-based B2B and B2C venture which aims to offer superior music quality and music videos to radio stations via software applications.

 

Shares in Rosedog Ltd are valued at $1,600,000 representing a 29.9% holding. This shareholding has been valued on a Price of Recent Investment basis which the directors consider represents the best indication of the fair value at the year end. Rosedog Ltd is the owner of Pro Vitos™, an online marketer of vitamins and diet supplements and Omega 3 North Norway™, a distributor of branded diet supplements.

 

Shares in YRRO Ltd are valued at $1,600,000 representing a 29.9% holding. This shareholding has been valued on a Price of Recent Investment basis which the directors consider represents the best indication of the fair value at the year end. YRRO is the owner of Ocean Skin Labs™, a distributor of branded collagen supplements and Norwegian Fish Oil™, a distributor of branded diet supplements.

 

The businesses of all of the above portfolio investments are presently loss-making although their cost bases are low and there is minimal committed future expenditure, meaning that the extent and timing of the Company's further investment in the businesses are highly controllable. The Company and the incumbent management teams of the investee companies will continue to work together with the aim that these businesses become financially self-sustaining and generating surpluses within the short- to medium-term and to crystallise additional capital value for shareholders through strategic, third-party partnerships.

 

 

5. Called up share capital

Authorised, issued and fully paid share capital as at 30 November 2020 is as follows:

Number

Class:

Nominal

30 Nov

31 May

 

Value

2020

2020

(Unaudited)

(Audited)

$'000

$'000

3,863,590

Ordinary

$1.00

3,802

3,802

3,802

3,802

The aggregate nominal values of the ordinary shares include exchange differences arising from the translation of shares at historic rates and the translation at the rate prevailing at the date of the change in functional currency.

 

During the year ended 31 May 2018, the Company extended the time scale of 78,632 fully transferable exercisable warrants which were originally issued in the year ended 31 May 2012. At the date of issue, the warrants could be exercised on or before 30 June 2014, this period has now been extended to 30 June 2020. The warrants are exercisable at a price of $15.00 per share.

 

 

 

9

CRAVEN HOUSE CAPITAL PLC

 

NOTES TO THE FINANCIAL INFORMATION - continued

FOR THE SIX MONTH PERIOD ENDED 30 NOVEMBER 2020

 

 

6. Earnings per share

 

The calculation of basic earnings per share is based on the loss attributable to the equity holders of $119,000 divided by the weighted average number of shares in issue during the period of 3,863,590 (six months ended 30 November 2019: loss of $5,676,000 and 2,537,354 shares; year ended 31 May 2020: loss of $13,187,000 and 2,888,529 shares).

 

Diluted earnings per share has not been disclosed as the inclusion of the unexercised warrants described in note 5 would be non-dilutive.

 

7. Convertible loan note

 

As part of the group reconstruction in May 2020, $500,000 of the convertible loan note which was outstanding at 30 November 2019 was assigned to the Company's wholly owned subsidiary, Craven Industrial Holdings Plc.

 

 

8. Related party disclosures

 

Craven Industrial Holdings Plc

During the period, now commonly owned, former subsidiary Craven Industrial Holdings Plc paid costs on behalf of and advanced loans to the Company. At the period end, the outstanding balance due to Craven Industrial Holdings Plc was $204,241.

 

9. Events after the reporting period 

 

On 9 December 2020, the Company announced that Black Seas Property AS ("BSP") entered into a 6 month option agreement to acquire certain brand names and associated rights from its investee company YRRO Ltd. Under the terms of the agreement, consideration payable of NOK 130,000,000 is to be settled by the issuance of new shares in BSP to the shareholders of YRRO Ltd.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EVLFFFLLBBBX
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.